FBXW7 and breast carcinoma: Another study from Reiterer et al. indicated that STYX inhibits the apoptosis of breast cancer cells by binding the F-box and WD repeat domain-containing 7 (FBXW7) protein and inhibiting the formation of SCFFBXW7 complex, thereby affecting the cellular levels of FBXW7 substrates [8].